Your browser doesn't support javascript.
loading
KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema.
Wykoff, Charles C; Garweg, Justus G; Regillo, Carl; Souied, Eric; Wolf, Sebastian; Dhoot, Dilsher S; Agostini, Hansjuergen T; Chang, Andrew; Laude, Augustinus; Wachtlin, Joachim; Kovacic, Lidija; Wang, Lixin; Wang, Ying; Bouillaud, Emmanuel; Brown, David M.
Affiliation
  • Wykoff CC; From the Retina Consultants of Texas (C.C.W., D.M.B.), Houston, Texas, USA. Electronic address: ccwmd@retinaconsultantstexas.com.
  • Garweg JG; Berner Augenklinik and Swiss Eye Institute (J.G.G.), Bern, Switzerland; Department of Ophthalmology (J.G.G., S.W.), Inselspital, University of Bern, Bern, Switzerland.
  • Regillo C; Retina Service (C.R.), Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Souied E; Department of Ophthalmology (E.S.), Hôpital Intercommunal de Creteil, Créteil, France.
  • Wolf S; Department of Ophthalmology (J.G.G., S.W.), Inselspital, University of Bern, Bern, Switzerland; Bern Photographic Reading Center (S.W.), Bern University Hospital, University of Bern, Bern, Switzerland.
  • Dhoot DS; California Retina Consultants (D.S.D.), Santa Barbara, California, USA.
  • Agostini HT; Department of Ophthalmology (H.T.A.), Medical Faculty, University of Freiburg, Freiburg, Germany.
  • Chang A; Sydney Retina Clinic (A.C.), Sydney Eye Hospital, Sydney University, New South Wales, Australia.
  • Laude A; National Healthcare Group Eye Institute (A.L.), Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine (A.L.), Nanyang Technological University, Singapore.
  • Wachtlin J; Sankt Gertrauden Hospital (J.W.), Berlin, Germany; MHB Medizinische Hochschule Brandenburg (J.W.), Neuruppin, Germany.
  • Kovacic L; Novartis Pharma A.G. (L.W., Y.W., E.B.), Basel, Switzerland.
  • Wang L; Novartis Pharma A.G. (L.W., Y.W., E.B.), Basel, Switzerland.
  • Wang Y; Novartis Pharma A.G. (L.W., Y.W., E.B.), Basel, Switzerland.
  • Bouillaud E; Novartis Pharma A.G. (L.W., Y.W., E.B.), Basel, Switzerland.
  • Brown DM; From the Retina Consultants of Texas (C.C.W., D.M.B.), Houston, Texas, USA.
Am J Ophthalmol ; 260: 70-83, 2024 Apr.
Article in En | MEDLINE | ID: mdl-37460036
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Macular Edema / Diabetes Mellitus / Diabetic Retinopathy / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Humans Language: En Year: 2024 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Macular Edema / Diabetes Mellitus / Diabetic Retinopathy / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Humans Language: En Year: 2024 Type: Article